Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in japanese patients

Pancreas

Volumn 43, Issue 7, 2014, Pages 1014-1017

  Mizuno, Suguru ^a   Nakai, Yousuke ^a   Isayama, Hiroyuki ^a   Kawahata, Shuhei ^a   Saito, Tomotaka ^a   Takagi, Kaoru ^a   Watanabe, Takeo ^a   Uchino, Rie ^a   Hamada, Tsuyoshi ^a   Miyabayashi, Koji ^a   Kogure, Hirofumi ^a   Sasaki, Takashi ^a   Yamamoto, Natsuyo ^a   Sasahira, Naoki ^a   Hirano, Kenji ^a   Tsujino, Takeshi ^a   Ijichi, Hideaki ^a   Tateishi, Keisuke ^a   Tada, Minoru ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Age of onset; Diabetes mellitus; Family history; Pancreatic cancer; Smoking

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AGED; BLOOD; BODY MASS; DIABETES MELLITUS; DRINKING BEHAVIOR; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; ONSET AGE; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDY; SMOKING; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SMOKING;

EID: 84914163275     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000158     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
2. Vital, Health and Social Statistics Division, Ministry of Health, Labour and Welfare. Vital Statistics Japan. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2011.
3. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004;2:606-621.
4. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006;4:766-781.
5. Ludwig E, Olson SH, Bayuga S, et al. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol. 2011;106:946-954.
6. Ghadirian P, Boyle P, Simard A, et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol. 1991;10:183-196.
7. Klein AP, Hruban RH, Brune KA, et al. Familial pancreatic cancer. Cancer J. 2001;7:266-273.
8. McWilliams RR, Bamlet WR, Rabe KG, et al. Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma. Clin Gastroenterol Hepatol. 2006;4:1143-1147.
9. Brand RE, Greer JB, Zolotarevsky E, et al. Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clin Gastroenterol Hepatol. 2009;7:1007-1012.
10. Anderson MA, Zolotarevsky E, Cooper KL, et al. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol. 2012;107:1730-1739.
11. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92:2076-2083.
12. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995;273:1605-1609.
13. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134:95-101.
14. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134:981-987.
15. Pannala R, Leibson CL, Rabe KG, et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol. 2009;104:2318-2325.
16. Pannala R, Basu A, Petersen GM, et al. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10:88-95.
17. Ogawa Y, Tanaka M, Inoue K, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2002;94:2344-2349.
18. Mizuno S, Nakai Y, Isayama H, et al. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age. J Gastroenterol. 2013;48:238-246.
19. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer. 2003;89:519-523.
20. Hassan MM, Bondy ML, Wolff RA, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007;102:2696-2707.
21. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699-708.
22. Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011;47:1928-1937.
23. Matsubayashi H, Maeda A, Kanemoto H, et al. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas. 2011;40:974-978.
24. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 2001;286:169-170.
25. Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 2003;124:1292-1299.
26. Petersen GM, de Andrade M, Goggins M, et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2006;15:704-710.
27. Life-style Related Diseases Control General Affairs Division, Ministry of Health, Labour and Welfare. National Health and Nutrition Survey in Japan. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2011.
28. Li D, Yeung SC, Hassan MM, et al. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009;137:482-488.
29. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52:1766-1777.